Glassman Wealth Services Abb Vie Inc. Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $6,329 - $7,128	-46 Reduced 1.1%	4,153 $643,000
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $17,767 - $20,568	133 Added 3.27%	4,199 $625,000
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $92,889 - $115,594	-701 Reduced 14.71%	4,066 $547,000
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $12,291 - $14,155	85 Added 1.82%	4,767 $759,000
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $81,741 - $98,029	591 Added 14.45%	4,682 $757,000
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $13,286 - $15,239	99 Added 2.48%	4,091 $549,000
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $12,936 - $16,446	94 Added 2.41%	3,992 $611,000
Q1 2022 Aug 23, 2022	BUY	$131.98 - $163.75 $20,720 - $25,708	157 Added 4.2%	3,898 $632,000
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $19,533 - $24,235	148 Added 4.12%	3,741 $606,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $40,393 - $51,109	376 Added 11.69%	3,593 $486,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $241,847 - $274,532	2,273 Added 240.78%	3,217 $347,000
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $11,257 - $12,541	107 Added 12.78%	944 $106,000
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $7,774 - $8,559	-76 Reduced 8.32%	837 $91,000
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $402 - $543	-5 Reduced 0.54%	913 $98,000
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $20,274 - $23,795	236 Added 34.6%	918 $80,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $6,750 - $9,032	92 Added 15.59%	682 $67,000
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $193 - $293	-3 Reduced 0.51%	590 $45,000
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $8,006 - $10,017	111 Added 23.03%	593 $53,000
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $11,651 - $14,008	-185 Reduced 27.74%	482 $36,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $8,672 - $11,085	132 Added 24.67%	667 $49,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $12,573 - $14,798	163 Added 43.82%	535 $43,000
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $778 - $960	10 Added 2.76%	372 $34,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $10,491 - $11,663	-118 Reduced 24.58%	362 $34,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $808 - $956	9 Added 1.91%	480 $44,000
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $12,881 - $17,249	140 Added 42.3%	471 $45,000
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $5,015 - $5,499	56 Added 20.36%	331 $32,000
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $24,447 - $31,227	-350 Reduced 56.0%	275 $24,000
Q2 2017 Aug 09, 2017	BUY	N/A	625	625 $45,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account